Make sure to sign up for an account today for exclusive coupons and free shipping on orders over $75!
Maximum quantity allowed is 999
Please select the quantity
CAS RN: 53-19-0 | Product Number: M3304
Mitotane
×
![]()
×
Purity: >98.0%(GC)
Synonyms:
- 1-(2-Chlorophenyl)-1-(4-chlorophenyl)-2,2-dichloroethane
- 1-Chloro-2-[2,2-dichloro-1-(4-chlorophenyl)ethyl]benzene
- o,p'-DDD
Product Documents:
| Size | Unit Price | Philadelphia, PA | Portland, OR | Japan* | Quantity |
|---|---|---|---|---|---|
| 1G |
$97.00
|
1 | 1 | 4 |
|
| 5G |
$289.00
|
1 | Contact Us | 6 |
|
* Items in stock locally ship in 1-2 business days. Items from Japan stock are able to ship from a US warehouse within 2 weeks. Please contact TCI for lead times on items not in stock. Excludes regulated items and items that ship on ice.
* To send your quote request for bulk quantities, please click on the "Request Quote" button. Please note that we cannot offer bulk quantities for some products.
*TCI frequently reviews storage conditions to optimize them. Please note that the latest information on the storage temperature for the products is described on our website.
| Product Number | M3304 |
| Purity / Analysis Method | >98.0%(GC) |
| Molecular Formula / Molecular Weight | C__1__4H__1__0Cl__4 = 320.03 |
| Physical State (20 deg.C) | Solid |
| Storage Temperature | Room Temperature (Recommended in a cool and dark place, <15°C) |
| Packaging and Container | 1G-Glass Bottle with Plastic Insert (View image) |
| CAS RN | 53-19-0 |
| Reaxys Registry Number | 2056007 |
| PubChem Substance ID | 468592398 |
| Merck Index (14) | 6216 |
| MDL Number | MFCD00000850 |
Specifications
| Appearance | White to Almost white powder to crystal |
| Purity(GC) | min. 98.0 % |
| Melting point | 76.0 to 80.0 °C |
| Solubility in Methanol | almost transparency |
| NMR | confirm to structure |
Properties (reference)
| Melting Point | 78 °C |
| Solubility in water | Insoluble |
| Degree of solubility in water | 0.1 mg/l 25 °C |
| Solubility (soluble in) | Ethanol, Methanol |
GHS
| Pictogram |
|
| Signal Word | Danger |
| Hazard Statements | H370 : Causes damage to organs. H372 : Causes damage to organs through prolonged or repeated exposure. H351 : Suspected of causing cancer. H413 : May cause long lasting harmful effects to aquatic life. |
| Precautionary Statements | P501 : Dispose of contents/ container to an approved waste disposal plant. P273 : Avoid release to the environment. P260 : Do not breathe dust/ fume/ gas/ mist/ vapors/ spray. P270 : Do not eat, drink or smoke when using this product. P202 : Do not handle until all safety precautions have been read and understood. P201 : Obtain special instructions before use. P264 : Wash skin thoroughly after handling. P280 : Wear protective gloves/ protective clothing/ eye protection/ face protection. P307 + P311 : IF exposed: Call a POISON CENTER or doctor/ physician. P405 : Store locked up. |
Related Laws:
| RTECS# | KH7880000 |
Transport Information:
| HS Number | 2903.99.3000 |
Application
Mitotane: An Adrenal-Specific Cytotoxic Agent with Steroid Synthesis Inhibition
Mitotane (o,p'-DDD) is an adrenal-specific cytotoxic agent with an unknown biochemical mechanism of action.1) Scientific reports suggest that mitotane modifies the peripheral metabolism of steroids as well as directly suppressing the adrenal cortex.2-4) Therefore, mitotane is used for the treatment of adrenocortical carcinoma (ACC) and Cushing's disease. Recently, mitotane (as an adjuvant) plus etoposide [E0675], doxorubicin [D4193] (HCl salt), and cisplatin [D3371] (called EDP-M) is the established first-line therapy for ACC.5) (The product is for research purpose only.)
References
- 1) Ultrastructure of Adrenal Cortex of the Dog during Treatment with DDD
- 2) Studies on the site of action of o,p’-DDD in the dog adrenal cortex. 1. Inhibition of ACTH-mediated pregnenolone synthesis
- 3) Changes in corticosteroid synthesis of the human adrenal cortex in vitro, induced by treatment with o,p'-DDD for cushing's syndrome: evidence for the sites of action of the drug
- 4) An Effect of o,p’-DDD on the Extra-adrenal Metabolism of Cortisol in Man
- 5) Update in adrenocortical carcinoma (a review)
Product Documents (Note: Some products will not have analytical charts available.)
Safety Data Sheet (SDS)
Please select Language.
The requested SDS is not available.
Please Contact Us for more information.
Specifications
C of A & Other Certificates
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
Sample C of A
This is a sample C of A and may not represent a recently manufactured lot of the product.
A sample C of A for this product is not available at this time.
Analytical Charts
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
The requested analytical chart is not available. Sorry for the inconvenience.